macrophages Produce TGF-β-induced (β-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 5036-5044

  Nacu, Natalia ^a   Luzina, Irina G ^a,b   Highsmith, Kendrick ^b   Lockatell, Virginia ^a   Pochetuhen, Kerill ^a   Cooper, Zachary A ^a   Gillmeister, Michael P ^b   Todd, Nevins W ^a,b   Atamas, Sergei P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; KERATOEPITHELIN; MATRIX METALLOPROTEINASE 14; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BETAIG H3 PROTEIN; BETAIG-H3 PROTEIN; DNA; MMP14 PROTEIN, HUMAN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; SCLEROPROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; BONE TURNOVER; CELL CULTURE; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; DNA BINDING; ENZYME REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MOLECULAR MECHANICS; MONOCYTE; NECROSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; UPREGULATION; WOUND HEALING; BIOSYNTHESIS; CYTOLOGY; GENETICS; METABOLISM; PROTEIN BINDING;

APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; DNA; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASE 14; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 44449101196     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.5036     Document Type: Article

References (36)

1. Huynh, M. L., V. A. Fadok, and P. M. Henson. 2002. Phosphatidylserine- depen- dent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109: 41-50.
2. Xiao, Y. Q., K. Malcolm, G. S. Worthen, S. Gardai, W. P. Schiemann, V. A. Fadok, D. L. Bratton, and P. M. Henson. 2002. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-β J. Biol. Chem. 277: 14884-14893.
3. McDonald, P. P., V. A. Fadok, D. Bratton, and P. M. Henson. 1999. Transcrip-tional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells. J. Immunol. 163: 6164-6172.
4. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101: 890-898.
5. Atamas, S. P., and B. White. 2003. Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev. 14: 537-550.
6. Martin, P., D. D'Souza, J. Martin, R. Grose, L. Cooper, R. Maki, and S. R. McKercher. 2003. Wound healing in the PU. 1 null mice: tissue repair is not dependent on inflammatory cells. Curr. Biol. 13: 1122-1128.
7. Reynolds, H. Y. 2005. Lung inflammation and fibrosis: an alveolar macrophage- centered perspective from the 1970s to 1980s. Am. J. Respir. Crit. Care Med. 171: 98 -102.
8. Prasse, A., D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel. 2006. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 173: 781-792.
9. Zhang-Hoover, J., A. Sutton, N. van Rooijen, and J. Stein-Streilein. 2000. A critical role for alveolar macrophages in elicitation of pulmonary immune fibro- sis. Immunology 101: 501-511.
10. Yamate, J., K. Sato, M. Ide, M. Nakanishi, M. Kuwamura, S. Sakuma, and S. Nakatsuji. 2002. Participation of different macrophage populations and myofibro- blastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet. Pathol. 39: 322-333.
11. Chow, F. Y., D. J. Nikolic-Paterson, R. C. Atkins, and G. H. Tesch. 2004. Mac- rophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol. Dial. Transplant. 19: 2987-2996.
12. Duffield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115: 56 -65.
13. Wang, L., J. F. Scabilloni, J. M. Antonini, Y. Rojanasakul, V. Castranova, and R. R. Mercer. 2006. Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. Am. J. Physiol.290: L695-L702.
14. Docherty, N. G., O. E. O'Sullivan, D. A. Healy, J. M. Fitzpatrick, and R. W. Watson. 2006. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am. J. Physiol. 290: F4-F13.
15. Canbay, A., H. Higuchi, S. F. Bronk, M. Taniai, T. J. Sebo, and G. J. Gores. 2002. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123: 1323-1330.
16. Mora, A. L., E. Torres-Gonzalez, C. Corredor, J. Ritzenthaler, J. Xu, J. Roman, K. Brigham, and A. Stecenko. 2006. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35: 466 -473.
17. Kahari, V. M., Y. Q. Chen, M. W. Su, F. Ramirez, and J. Uitto. 1990. Tumor necrosis factor-a and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1: evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J. Clin. Invest. 86: 1489 -1495.
18. Fine, A., and R. H. Goldstein. 1987. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 262: 3897-3902.
19. + lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum. 42: 1168 -1178.
20. Luzina, I. G., S. P. Atamas, R. Wise, F. M. Wigley, H. Q. Xiao, and B. White. 2002. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am. J. Respir. Cell Mol. Biol. 26: 549 -557.
21. + T cells from scleroderma patients. Arthritis Rheum. 48: 2262-2274.
22. Atamas, S. P., I. G. Luzina, J. Choi, N. Tsymbalyuk, N. H. Carbonetti, I. S. Singh, M. Trojanowska, S. A. Jimenez, and B. White. 2003. Pulmonary and activation- regulated chemokine stimulates collagen production in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 29: 743-749.
23. Luzina, I. G., N. Tsymbalyuk, J. Choi, J. D. Hasday, and S. P. Atamas. 2006. CCL18-stimulated upregulation of collagen production in lung fibroblasts re quires Sp1 signaling and basal Smad3 activity. J. Cell. Physiol. 206: 221-228.
24. Atamas, S. P., I. G. Luzina, H. Dai, S. G. Wilt, and B. White. 2002. Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J. Immunol. 168: 1139 -1145.
25. Luzina, I. G., K. Highsmith, K. Pochetuhen, N. Nacu, J. N. Rao, and S. P. Atamas. 2006. PKCα mediates CCL18-stimulated collagen production in pulmonary fibroblasts. Am. J. Respir. Cell Mol. Biol. 35: 298-305.
26. Luzina, I. G., J. C. Papadimitriou, R. Anderson, K. Pochetuhen, and S. P. Atamas. 2006. Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum. 54: 2643-2655.
27. Gratchev, A., P. Guillot, N. Hakiy, O. Politz, C. E. Orfanos, K. Schledzewski, and S. Goerdt. 2001. Alternatively activated macrophages differentially express fi- bronectin and its splice variants and the extracellular matrix protein βIG-H3. Scand. J. Immunol. 53: 386 -392.
28. Song, E., N. Quyang, M. Horbelt, B. Antus, M. Wang, and M. S. Exton. 2000. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204: 19-28.
29. Porcheray, V., S. Viaud, A. C. Rimaniol, C. Leone, B. Samah, N. Dereuddre- Bosquet, D. Dormont, and G. Gras. 2005. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142: 481-489.
30. Lee, H., C. M. Overall, C. A. McCulloch, and J. Sodek. 2006. A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol. Biol. Cell 17: 4812-4826.
31. Takabayshi, K., M. Corr, T. Hayashi, V. Redecke, L. Beck, D. Guiney, D. Sheppard, and E. Raz. 2006. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 24: 475-487.
32. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
33. Okada, A., C. Tomasetto, Y. Lutz, J. P. Bellocq, M. C. Rio, and P. Basset. 1997.
34. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro- gellatinase A. J. Cell Biol. 137: 67-77.
35. Holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S. A. Kuznetsov, M. Mankani, P. G. Robey, A. R. Poole, I. Pidoux, et al. 1999. MT1-MMP- deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92.
36. Ghosh, A. K., S. Bhattacharyya, and J. Varga. 2004. The tumor supressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells. J. Biol. Chem. 279: 47455-47463.